Authors: Lara, PN Higdon, R Lim, N Kwan, K Tanaka, M Lau, DHM Wun, T Welborn, J Meyers, FJ Christensen, S O'Donnell, R Richman, C Scudder, SA Tuscano, J Gandara, DR Lam, KS

Citation: Pn. Lara et al., Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment, J CL ONCOL, 19(6), 2001, pp. 1728-1733

Authors: Costa, MJ Hansen, CL Walls, JE Scudder, SA

Citation: Mj. Costa et al., Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/C1P1) predicts survival and good response to platinin-based chemotherapy, HUMAN PATH, 30(6), 1999, pp. 640-647

Authors: Weiss, GR Liu, PY Alberts, DS Peng, YM Fisher, E Xu, MJ Scudder, SA Baker, LH Moore, DF Lippman, SM

Citation: Gr. Weiss et al., 13-cis-retinoic acid or all-trans-retinoic acid plus inteferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial, GYNECOL ONC, 71(3), 1998, pp. 386-390